Organoids for Toxicity & Safety Assessment

English

Overview

Organoids are physiologically relevant models for toxicity and safety assessment. Compared with conventional 2D cultures, they better recapitulate tissue architecture, electrophysiology, and organ-specific responses, providing a more representative model for preclinical research.

Within New Approach Methodologies (NAMs), organoids enable human-relevant toxicity testing and safety assessment, helping reduce reliance on animal models and support more translational research.

ACROBiosystems offers validated organoid models and supporting culture kits to enable reproducible toxicity screening and translational safety assessment with human-relevant data.

Explore by Subtopics

No results found

Frequently Asked Questions

What organoid solutions does ACROBiosystems offer?

We offer a growing portfolio of validated organoid models across multiple organ systems, together with supporting maintenance kits and essential reagents, including ultra-low-attachment cell culture plates, basement membrane extract, and growth factors. We also provide organoid-related services, including microelectrode array (MEA) analysis, to support functional characterization and downstream research.

How are organoids used for toxicity assessment in NAMs?

Organoids can be used within New Approach Methodologies (NAMs) for drug toxicity screening and safety assessment. By capturing tissue-specific responses in a human-relevant 3D model, they provide complementary data to support preclinical evaluation and help reduce reliance on animal testing.

What are organoids?

Organoids are three-dimensional (3D) in vitro models that self-organize and differentiate to recapitulate key structural and functional features of native tissues. They provide physiologically relevant models for studying human biology, disease mechanisms, and tissue-specific responses.